Bumetanide and Yaz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bumetanide (bumetanide) and Yaz (drospirenone; ethinyl estradiol). Common drug interactions include pain among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Bumetanide and Yaz. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.

What is Yaz?

Yaz has active ingredients of drospirenone; ethinyl estradiol. It is often used in birth control. eHealthMe is studying from 41,514 Yaz users. Check the latest studies of Yaz.



On Aug, 01, 2026

11 people who take Bumetanide and Yaz together, and have interactions are studied.

Bumetanide and Yaz drug interactions.

What are the common drug interactions of Bumetanide and Yaz, by gender? *:

female:

  1. Pain
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Oedema peripheral (superficial swelling)
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Injury
  6. Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)
  7. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  8. Abdominal pain upper
  9. Aphasia (damage to the parts of the brain that control language)
  10. Arthralgia (joint pain)

male:

  1. Anxiety
  2. Emotional distress
  3. Concomitant disease progression (progress in accompanying disease)
  4. Confusional state
  5. Dyslalia (inability to articulate comprehensible speech)
  6. Fear
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Memory impairment
  9. Mobility decreased (ability to move is reduced)
  10. Nervousness

What are the common drug interactions of Bumetanide and Yaz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Pulmonary embolism (blockage of the main artery of the lung)

30-39:

  1. Pain
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Oedema peripheral (superficial swelling)
  4. Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)
  5. Abdominal pain upper
  6. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  7. Cholecystitis chronic (long lasting infection of gallbladder)
  8. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  9. Cholesterosis (abnormal deposition of cholesterol in tissues)
  10. Stress

40-49:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Depression
  5. Dyspnoea (difficult or laboured respiration)
  6. Fatigue (feeling of tiredness)
  7. Gallbladder disorder
  8. Injury
  9. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  10. Mood swings (an extreme or rapid change in mood)

50-59:

n/a

60+:

  1. Pain
  2. Injury
  3. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  4. Concomitant disease progression (progress in accompanying disease)
  5. Confusional state
  6. Dyslalia (inability to articulate comprehensible speech)
  7. Fear
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Memory impairment
  10. Mobility decreased (ability to move is reduced)

What are the existing conditions these people have? *

  1. Stress And Anxiety: 3 people, 27.27%
  2. High Blood Pressure: 2 people, 18.18%
  3. Cardiac Failure: 2 people, 18.18%
  4. Depression: 2 people, 18.18%
  5. Acne (skin problems that cause pimples): 2 people, 18.18%
  6. Swelling: 1 person, 9.09%
  7. Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 9.09%
  8. Anaemia (lack of blood): 1 person, 9.09%
  9. Cardiac Disorder: 1 person, 9.09%
  10. Thrush (an infection of the mouth caused by the candida fungus): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Bumetanide and Yaz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Bumetanide and Yaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Yaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bumetanide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Yaz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on bumetanide and drospirenone; ethinyl estradiol (the active ingredients of Bumetanide and Yaz, respectively), and Bumetanide and Yaz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: